Literature DB >> 17139538

Optimized transduction of canine paediatric CD34(+) cells using an MSCV-based bicistronic vector.

S E Suter1, T A Gouthro, P A McSweeney, R A Nash, M E Haskins, P J Felsburg, P S Henthorn.   

Abstract

We have used a murine MSCV-based bicistronic retroviral vector, containing the common gamma chain (gammac) and enhanced green fluorescent protein (EGFP) cDNAs, to optimize retroviral transduction of canine cells, including an adherent canine thymus fibroblast cell line, Cf2Th, as well as normal canine CD34(+) bone marrow (BM) cells. Both canine cell types were shown to express Ram-1 (the amphotropic retroviral receptor) mRNA. Supernatants containing infectious viruses were produced using both stable (PA317) and transient (Phoenix cells) amphotropic virus producer cell lines. Centrifugation (spinfection) combined with the addition of polybrene produced the highest transduction efficiencies, infecting approximately 75% of Cf2Th cells. An average of 11% of highly enriched canine CD34(+) cells could be transduced in a protocol that utilized spinfection and plates coated with the fibronectin fragment CH-296 (Retronectin). Indirect assays showed the vector-encoded canine gammac cDNA produced a gammac protein that was expressed on the cell surface of transduced cells. This strategy may result in the transduction of sufficient numbers of CD34(+) BM cells to make the treatment of canine X-linked severe combined immunodeficiency and other canine genetic diseases feasible.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17139538     DOI: 10.1007/s11259-006-3356-7

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  89 in total

1.  X-linked severe combined immunodeficiency in a family of Cardigan Welsh corgis.

Authors:  R P Pullen; R L Somberg; P J Felsburg; P S Henthorn
Journal:  J Am Anim Hosp Assoc       Date:  1997 Nov-Dec       Impact factor: 1.023

2.  Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population.

Authors:  Q L Hao; F T Thiemann; D Petersen; E M Smogorzewska; G M Crooks
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

Review 3.  Gene transfer into hematopoietic stem cells of nonhuman primates.

Authors:  V W Van Beusechem; D Valerio
Journal:  Hum Gene Ther       Date:  1996-09-10       Impact factor: 5.695

4.  The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs.

Authors:  M Goerner; B Bruno; P A McSweeney; G Buron; R Storb; H P Kiem
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

Review 5.  The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.

Authors:  K Sugamura; H Asao; M Kondo; N Tanaka; N Ishii; K Ohbo; M Nakamura; T Takeshita
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

6.  Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors.

Authors:  M Goerner; P A Horn; L Peterson; P Kurre; R Storb; J E Rasko; H P Kiem
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

7.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells.

Authors:  H Hanenberg; X L Xiao; D Dilloo; K Hashino; I Kato; D A Williams
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

8.  Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation.

Authors:  D Bienzle; A C Abrams-Ogg; S A Kruth; J Ackland-Snow; R F Carter; J E Dick; R M Jacobs; S Kamel-Reid; I D Dubé
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I.

Authors:  K P Menon; P T Tieu; E F Neufeld
Journal:  Genomics       Date:  1992-11       Impact factor: 5.736

10.  Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

Authors:  Virginie Sandrin; Bertrand Boson; Patrick Salmon; Wilfried Gay; Didier Nègre; Roger Le Grand; Didier Trono; François-Loïc Cosset
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

View more
  5 in total

1.  Effects of over-expression of ANXA10 gene on proliferation and apoptosis of hepatocellular carcinoma cell line HepG2.

Authors:  Xiaohui Liu; Xiaodong Peng; Zhenzhen Hu; Qingmei Zhao; Jian He; Junhe Li; Xiaojun Zhong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

2.  Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma.

Authors:  Douglas R Kennedy; Brian J Hartnett; Jeffrey S Kennedy; William Vernau; Peter F Moore; Thomas O'Malley; Linda C Burkly; Paula S Henthorn; Peter J Felsburg
Journal:  Vet Immunol Immunopathol       Date:  2011-04-14       Impact factor: 2.046

3.  Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis.

Authors:  Carol G Chen; Daniel Thuillier; Emily N Chin; Tamara Alliston
Journal:  Arthritis Rheum       Date:  2012-10

4.  Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.

Authors:  Jinshui Chen; Yun Song; Damir Bojadzic; Alejandro Tamayo-Garcia; Ana Marie Landin; Bonnie B Blomberg; Peter Buchwald
Journal:  J Med Chem       Date:  2017-10-25       Impact factor: 7.446

5.  Smad4 regulates growth plate matrix production and chondrocyte polarity.

Authors:  Amanda T Whitaker; Ellora Berthet; Andrea Cantu; Diana J Laird; Tamara Alliston
Journal:  Biol Open       Date:  2017-03-15       Impact factor: 2.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.